Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also ...

Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

When Lisa Lightner's son Kevin was two years old, she discovered that he would need special learning support in school. She has spent more than 12 years working to make sure he received the ...

Progressive forms of MS, including PPMS, are considered more severe than relapsing-remitting MS because they inevitably lead to disability, according to Coyle.

Dyscalculia Dysgraphia Visual processing disorder Auditory processing disorder As with dyslexia, symptoms of these co-occurring conditions will begin to appear early in a child’s life.

Many factors can influence the selection of disease modifying therapies (DMTs) in patients with relapsing multiple sclerosis (MS), such as efficacy and administration frequency. In this article ...

We proposed to test the long-term effectiveness of a 6-week fatigue programme supplemented with four booster sessions (‘FACETS+’) in patients with relapsing remitting MS (RRMS) and fatigue. Methods ...

Stay informed with NevadaAppeal.com, Carson City's trusted source for breaking news, politics, sports, and community updates.